The FDA cautioned that a drug class called tumor necrosis factor inhibitors has been associated with hepatosplenic T-cell lymphoma, particularly among teens and young adults. A majority of the cases involved patients treated for ulcerative colitis or Crohn's disease. Labels have been updated for Johnson & Johnson's Remicade and Abbott Laboratories' Humira, the FDA said.

Full Story:

Related Summaries